The Journal.

The Two Scientists Taking Down Cold Medicines That Don't Work


Listen Later

Randy Hatton and Leslie Hendeles spent nearly two decades trying to convince the Food and Drug Administration that phenylephrine, a drug commonly used in cold medicines, was ineffective. In September, an advisory panel finally agreed. Now, some of the medicines are being pulled from store shelves.

Further Reading:

- If Some Cold Medicines Don’t Work, What Should You Take for a Stuffy Nose? 

- CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling Them 

- These Are the Two Scientists Taking Down Cold Medicines That Don’t Work 



Learn more about your ad choices. Visit megaphone.fm/adchoices

...more
View all episodesView all episodes
Download on the App Store

The Journal.By The Wall Street Journal & Spotify Studios

  • 4.2
  • 4.2
  • 4.2
  • 4.2
  • 4.2

4.2

5,610 ratings


More shows like The Journal.

View all
Planet Money by NPR

Planet Money

30,838 Listeners

WSJ Opinion: Potomac Watch by Paul Gigot, The Wall Street Journal

WSJ Opinion: Potomac Watch

2,863 Listeners

WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,719 Listeners

WSJ What’s News by The Wall Street Journal

WSJ What’s News

4,361 Listeners

Odd Lots by Bloomberg

Odd Lots

1,977 Listeners

WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,654 Listeners

The Daily by The New York Times

The Daily

112,856 Listeners

WSJ Minute Briefing by The Wall Street Journal

WSJ Minute Briefing

674 Listeners

Up First from NPR by NPR

Up First from NPR

56,902 Listeners

Bold Names by The Wall Street Journal

Bold Names

1,451 Listeners

Wall Street Breakfast by Seeking Alpha

Wall Street Breakfast

1,046 Listeners

Post Reports by The Washington Post

Post Reports

5,478 Listeners

Barron's Streetwise by Barron's

Barron's Streetwise

1,568 Listeners

The Big Take by Bloomberg

The Big Take

155 Listeners

Bad Bets by The Wall Street Journal

Bad Bets

1,324 Listeners

WSJ Opinion: Free Expression by Gerard Baker, Editor at Large, The Wall Street Journal

WSJ Opinion: Free Expression

590 Listeners

As We Work by The Wall Street Journal

As We Work

151 Listeners

WSJ's Take On the Week by The Wall Street Journal

WSJ's Take On the Week

141 Listeners